Please enable JavaScript to continue using this application.

Compare $KYTX vs $SCTX | Chartloom

Compare

$KYTX vs $SCTX

Kyverna Therapeutics Inc · Scribe Therapeutics Inc

KYTX

Kyverna Therapeutics Inc

SCTX

Scribe Therapeutics Inc

Compare $KYTX vs $SCTX

Comparing Kyverna Therapeutics Inc and Scribe Therapeutics Inc

KYTXKyverna Therapeutics Inc

SCTXScribe Therapeutics Inc

KYTXKyverna Therapeutics Inc

Market cap

$389M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-27.1%

52W performance

-11.0%

FCF yield

-41.2%

SCTXScribe Therapeutics Inc

Market cap

$372M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

29.61x

Rev growth (TTM)

—

YTD performance

-2.2%

52W performance

-2.2%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KYTX

SCTX

Detailed metrics comparison

KYTX

Kyverna Therapeutics Inc

SCTX

Scribe Therapeutics Inc

Market Cap

KYTX$389M

SCTX$372M

Enterprise Value

KYTX$382M

SCTX$374M

Price

KYTX$6.39

SCTX$21.17

P/E Ratio

KYTXN/A

SCTXN/A

P/S Ratio

KYTX0.00x

SCTX0.00x

EV/Sales

KYTX0.00x

SCTX0.00x

EV/EBITDA

KYTX0.00x

SCTX0.00x

P/B Ratio

KYTX2.32x

SCTXN/A

P/FCF Ratio

KYTXN/A

SCTXN/A

EV/FCF

KYTX-2.38x

SCTX0.00x

PEG Ratio

KYTXN/A

SCTXN/A

Forward P/E (NTM)

KYTXN/A

SCTXN/A

Forward P/S (NTM)

KYTXN/A

SCTX29.61x

Revenue (TTM)

KYTX$0

SCTX$0

Revenue Growth (YoY)

KYTXN/A

SCTXN/A

Forward Rev Growth

KYTX252.6%

SCTX-43.3%

Gross Margin (TTM)

KYTX0.0%

SCTX0.0%

Operating Margin (TTM)

KYTX0.0%

SCTX0.0%

EBITDA Margin (TTM)

KYTX0.0%

SCTX0.0%

Net Margin (TTM)

KYTX0.0%

SCTX0.0%

FCF Margin (TTM)

KYTXN/A

SCTXN/A

Net Income (TTM)

KYTX$-153M

SCTXN/A

FCF (TTM)

KYTX$-160M

SCTX$0

EPS (TTM)

KYTX-$2.51

SCTX$0.00

ROE (TTM)

KYTX-8191.0%

SCTX0.0%

ROA (TTM)

KYTX-6374.0%

SCTX0.0%

ROIC (TTM)

KYTX-7440.0%

SCTX0.0%

Cash

KYTX$32M

SCTX$36M

Debt

KYTX$25M

SCTX$38M

Net Cash/Debt

KYTX$7M

SCTX$-2M

Current Ratio (TTM)

KYTX9.06x

SCTX0.57x

Quick Ratio (TTM)

KYTX8.75x

SCTX0.56x

Debt/Equity (TTM)

KYTX0.15x

SCTX0.00x

Debt/Assets (TTM)

KYTX0.0%

SCTX0.0%

Interest Coverage (TTM)

KYTXN/A

SCTXN/A

Net Debt/EBITDA (TTM)

KYTX0.00x

SCTX0.00x

Beta

KYTX2.11

SCTX-2.64

52W Performance

KYTX-11.0%

SCTX-2.2%

YTD Performance

KYTX-27.1%

SCTX-2.2%

% from 52W High

KYTX-53.3%

SCTX-46.5%

% from 52W Low

KYTX7.2%

SCTX56.8%

Asset Turnover (TTM)

KYTX0.00x

SCTX0.00x

FCF Yield (TTM)

KYTX-41.2%

SCTX0.0%

Earnings Yield (TTM)

KYTX-39.3%

SCTX0.0%

Dividend Yield (TTM)

KYTXN/A

SCTXN/A

Rule of 40

KYTX0.0

SCTX0.0

EV/GP/RG

KYTXN/A

SCTXN/A

Ticker research

View KYTX research View SCTX research

Metric	KYTX Kyverna Therapeutics Inc	SCTX Scribe Therapeutics Inc
Market & Valuation
Market Cap	$389M	$372M
Enterprise Value	$382M	$374M
Price	$6.39	$21.17
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.32x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-2.38x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	29.61x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	252.6%	-43.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-153M	N/A
FCF (TTM)	$-160M	$0
EPS (TTM)	-$2.51	$0.00
ROE (TTM)	-8191.0%	0.0%
ROA (TTM)	-6374.0%	0.0%
ROIC (TTM)	-7440.0%	0.0%
Financial Health
Cash	$32M	$36M
Debt	$25M	$38M
Net Cash/Debt	$7M	$-2M
Current Ratio (TTM)	9.06x	0.57x
Quick Ratio (TTM)	8.75x	0.56x
Debt/Equity (TTM)	0.15x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.11	-2.64
52W Performance	-11.0%	-2.2%
YTD Performance	-27.1%	-2.2%
% from 52W High	-53.3%	-46.5%
% from 52W Low	7.2%	56.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-41.2%	0.0%
Earnings Yield (TTM)	-39.3%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View KYTX research	View SCTX research

Valuation

P/S Ratio

KYTX

0.00x

SCTX

0.00x

EV/FCF

KYTX

-2.38x

SCTX

0.00x

Growth & revenue

Forward Revenue Growth

KYTX

252.6%

SCTX

-43.3%

Profitability & performance

Gross Margin

KYTX

0.0%

SCTX

0.0%

ROE

SCTX

0.0%

KYTX

-8191.0%

FCF Yield %

SCTX

0.0%

KYTX

-41.2%

52-Week Performance

SCTX

-2.2%

KYTX

-11.0%

Detailed metrics comparison

KYTX

Kyverna Therapeutics Inc

SCTX

Scribe Therapeutics Inc

Market Cap

KYTX$389M

SCTX$372M

Enterprise Value

KYTX$382M

SCTX$374M

Price

KYTX$6.39

SCTX$21.17

P/E Ratio

KYTXN/A

SCTXN/A

P/S Ratio

KYTX0.00x

SCTX0.00x

EV/Sales

KYTX0.00x

SCTX0.00x

EV/EBITDA

KYTX0.00x

SCTX0.00x

P/B Ratio

KYTX2.32x

SCTXN/A

P/FCF Ratio

KYTXN/A

SCTXN/A

EV/FCF

KYTX-2.38x

SCTX0.00x

PEG Ratio

KYTXN/A

SCTXN/A

Forward P/E (NTM)

KYTXN/A

SCTXN/A

Forward P/S (NTM)

KYTXN/A

SCTX29.61x

Revenue (TTM)

KYTX$0

SCTX$0

Revenue Growth (YoY)

KYTXN/A

SCTXN/A

Forward Rev Growth

KYTX252.6%

SCTX-43.3%

Gross Margin (TTM)

KYTX0.0%

SCTX0.0%

Operating Margin (TTM)

KYTX0.0%

SCTX0.0%

EBITDA Margin (TTM)

KYTX0.0%

SCTX0.0%

Net Margin (TTM)

KYTX0.0%

SCTX0.0%

FCF Margin (TTM)

KYTXN/A

SCTXN/A

Net Income (TTM)

KYTX$-153M

SCTXN/A

FCF (TTM)

KYTX$-160M

SCTX$0

EPS (TTM)

KYTX-$2.51

SCTX$0.00

ROE (TTM)

KYTX-8191.0%

SCTX0.0%

ROA (TTM)

KYTX-6374.0%

SCTX0.0%

ROIC (TTM)

KYTX-7440.0%

SCTX0.0%

Cash

KYTX$32M

SCTX$36M

Debt

KYTX$25M

SCTX$38M

Net Cash/Debt

KYTX$7M

SCTX$-2M

Current Ratio (TTM)

KYTX9.06x

SCTX0.57x

Quick Ratio (TTM)

KYTX8.75x

SCTX0.56x

Debt/Equity (TTM)

KYTX0.15x

SCTX0.00x

Debt/Assets (TTM)

KYTX0.0%

SCTX0.0%

Interest Coverage (TTM)

KYTXN/A

SCTXN/A

Net Debt/EBITDA (TTM)

KYTX0.00x

SCTX0.00x

Beta

KYTX2.11

SCTX-2.64

52W Performance

KYTX-11.0%

SCTX-2.2%

YTD Performance

KYTX-27.1%

SCTX-2.2%

% from 52W High

KYTX-53.3%

SCTX-46.5%

% from 52W Low

KYTX7.2%

SCTX56.8%

Asset Turnover (TTM)

KYTX0.00x

SCTX0.00x

FCF Yield (TTM)

KYTX-41.2%

SCTX0.0%

Earnings Yield (TTM)

KYTX-39.3%

SCTX0.0%

Dividend Yield (TTM)

KYTXN/A

SCTXN/A

Rule of 40

KYTX0.0

SCTX0.0

EV/GP/RG

KYTXN/A

SCTXN/A

Ticker research

View KYTX research View SCTX research

Metric	KYTX Kyverna Therapeutics Inc	SCTX Scribe Therapeutics Inc
Market & Valuation
Market Cap	$389M	$372M
Enterprise Value	$382M	$374M
Price	$6.39	$21.17
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.32x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-2.38x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	29.61x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	252.6%	-43.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-153M	N/A
FCF (TTM)	$-160M	$0
EPS (TTM)	-$2.51	$0.00
ROE (TTM)	-8191.0%	0.0%
ROA (TTM)	-6374.0%	0.0%
ROIC (TTM)	-7440.0%	0.0%
Financial Health
Cash	$32M	$36M
Debt	$25M	$38M
Net Cash/Debt	$7M	$-2M
Current Ratio (TTM)	9.06x	0.57x
Quick Ratio (TTM)	8.75x	0.56x
Debt/Equity (TTM)	0.15x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.11	-2.64
52W Performance	-11.0%	-2.2%
YTD Performance	-27.1%	-2.2%
% from 52W High	-53.3%	-46.5%
% from 52W Low	7.2%	56.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-41.2%	0.0%
Earnings Yield (TTM)	-39.3%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View KYTX research	View SCTX research